How Big Pharma is fighting a Biden program to lower seniors' drug costs
Drug companies have tried to invalidate a program that would reduce the price of medications for high blood pressure, heart disease, cancer and diabetes.
Stay updated with breaking news from James Stansel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Drug companies have tried to invalidate a program that would reduce the price of medications for high blood pressure, heart disease, cancer and diabetes.
Drug companies have tried to invalidate a program that would reduce the price of medications for high blood pressure, heart disease, cancer and diabetes.
Drug companies have tried to invalidate a program that would reduce the price of medications for high blood pressure, heart disease, cancer and diabetes.
TRENTON, N.J. - Pharmaceutical giants are mounting a vigorous legal battle against President Biden’s plan to lower seniors’ prescription drug costs, urging federal judges here and around the country to invalidate a new program that aims to reduce the price of medications for high blood pressure, heart disease, cancer and diabetes. In a flurry of lawsuits, these drugmakers have blasted the government initiative as unconstitutional, defended their pricing practices and warned that regulation could
Hospital groups have filed a legal brief urging a federal court to reject drug manufacturers’ challenge to a Louisiana law that allows state hospitals to receive drug discounts dispensed at community pharmacies under a federal program.